Vaxcyte Inc
(PCVX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 518,670 | 611,512 | 397,451 | 545,134 | 531,033 |
| Marketable Securities | 934,027 | 875,006 | 682,776 | 720,550 | 756,031 |
| TOTAL | $1,481,479 | $1,517,072 | $1,095,954 | $1,295,434 | $1,310,317 |
| Non-Current Assets | |||||
| PPE Net | 125,973 | 84,835 | 79,626 | 11,431 | 16,420 |
| Investments And Advances | 399,243 | 413,247 | 162,675 | 168,564 | 153,726 |
| Other Non-Current Assets | 80,572 | 76,151 | 69,662 | 20,628 | 22,356 |
| TOTAL | $605,788 | $574,233 | $311,963 | $200,623 | $192,502 |
| Total Assets | $2,087,267 | $2,091,305 | $1,407,917 | $1,496,057 | $1,502,819 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 10,466 | 21,717 | 14,587 | 15,704 | 16,266 |
| Accrued Expenses | 22,153 | 54,171 | 59,815 | 15,021 | 19,180 |
| TOTAL | $82,847 | $87,104 | $145,338 | $85,558 | $60,216 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 18,288 | 20,218 | 22,111 | 7,783 | 9,227 |
| TOTAL | $18,288 | $20,218 | $22,111 | $7,783 | $9,227 |
| Total Liabilities | $101,135 | $107,322 | $167,449 | $93,341 | $69,443 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 111,610 | 108,795 | 108,408 | 95,154 | 93,847 |
| Common Shares | 114 | 112 | 98 | 98 | 97 |
| Retained earnings | -1,148,115 | -1,019,412 | -924,392 | -743,591 | -650,927 |
| Other shareholders' equity | 1,815 | 2,889 | 179 | -2,290 | -2,521 |
| TOTAL | $1,986,132 | $1,983,983 | $1,240,468 | $1,402,716 | $1,433,376 |
| Total Liabilities And Equity | $2,087,267 | $2,091,305 | $1,407,917 | $1,496,057 | $1,502,819 |